Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors

Dr. Joseph M. DeSimone Dr.Joseph M. DeSimone Executive Commentary "We are honored to welcome Josephine and Joe to our Board," said Bob Whitehead , Co-Founder and Executive Chairman of Continuity Biosciences. "Josephine's regulatory acumen and clear-eyed judgment are second to none. Joe is not only a visionary in drug delivery but also a trusted partner in our efforts through Focal Medical and PinPrint. Their expertise will be instrumental as we continue to scale our programs and...

Dr. Joseph M. DeSimone

Executive Commentary

"We are honored to welcome Josephine and Joe to our Board," said Bob Whitehead, Co-Founder and Executive Chairman of Continuity Biosciences. "Josephine's regulatory acumen and clear-eyed judgment are second to none. Joe is not only a visionary in drug delivery but also a trusted partner in our efforts through Focal Medical and PinPrint. Their expertise will be instrumental as we continue to scale our programs and build long-term value."

Torrente and DeSimone join Continuity's existing Board of Directors, which includes Bob Whitehead and Ramakrishna Venugopalan, PhD, MBA (Continuity's co-founders), Monica Reed, MD, Mike Fowler, and Allen Weiss.

About Continuity Biosciences

Founded in 2024, Continuity Biosciences is developing advanced delivery platforms for biologics and complex therapeutics, with a focus on precision targeting and tunable release. Operating in Houston (TX), Raleigh (NC), Bradenton (FL), and Torino (Italy), Continuity's pipeline spans oncology, metabolic diseases, infectious diseases, and women's health. Through strategic acquisitions—including Focal Medical—and targeted investments like PinPrint, Continuity is building a differentiated platform to transform the delivery of challenging therapeutics.

Logo - https://mma.prnewswire.com/media/2555793/Continuity_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/continuity-biosciences-appoints-josephine-torrente-and-joseph-desimone-phd-to-board-of-directors-302522793.html